J. Kerger

发表

Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer

J. Machiels, J. Canon, S. Oudard, 2012, Cancer Chemotherapy and Pharmacology.

Recurrence dynamics of breast cancer according to baseline body mass index.

C. Sotiriou, C. Desmedt, M. Piccart, 2017, European journal of cancer.

Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex.

M. Piccart, M. Egorin, N. Bachur, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Cetuximab, docetaxel, and cisplatin (TPEx) as first-line treatment in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial GORTEC 2008-03.

J. Machiels, C. Sire, S. Temam, 2011 .

Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study.

M. Piccart-Gebhart, M. Paesmans, E. de Azambuja, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment

R. Paridaens, C. Jackisch, M. Schwenkglenks, 2006, Supportive Care in Cancer.

Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.

M. Piccart, M. Paesmans, C. Focan, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterization and Clinical Utility of BRAFV600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma

B. Neyns, P. Pauwels, P. Rutkowski, 2021, Cancers.

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.

C. Sempoux, J. Machiels, V. Remouchamps, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.

R. Greil, B. Chauffert, S. Barni, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Cancer and renal insufficiency results of the BIRMA study

J. Machiels, H. Wildiers, J. Canon, 2010, British Journal of Cancer.

Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.

J. Machiels, B. Tombal, B. Filleul, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.

J. Bourhis, J. Machiels, C. Sire, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxelof its Use in the Treatment of Metastatic Breast Cancer and Ovarian and Other Gynaecological Cancers

M. Markman, A. Bois, J. Kerger, 1998 .

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

D. Larsimont, G. Liberale, M. Moreau, 2019, Journal of visceral surgery.

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

P. Coulie, Y. Humblet, B. Dréno, 1999, International journal of cancer.

New Drug Combination Strategies in Melanoma: Current Status and Future Directions.

G. Ghanem, A. Awada, F. Journé, 2017, Anticancer research.

Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review

H. Kourie, J. Kerger, A. Simon, 2017, Chinese journal of cancer.

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel

J. Machiels, M. Berlière, F. Dalenc, 2008, BMC Cancer.

Tumour stimulating effects of recombinant human interleukin-6

M. Piccart, J. Sculier, P. Lacor, 1994, The Lancet.

Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study

V. D’Hondt, F. Goffin, G. Liberale, 2016, International Journal of Gynecologic Cancer.

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients.

J. Verweij, R. de Wit, G. Stoter, 1998, British Journal of Cancer.

Incidence of reversible amenorrhea in women with early-stage breast cancer undergoing adjuvant anthracyclin-based chemotherapy with or without docetaxel.

J. Machiels, M. Berlière, F. Dalenc, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.

M. van Glabbeke, J. Verweij, A. V. van Oosterom, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade

S. Aspeslagh, S. Garaud, J. Kerger, 2019, Acta clinica Belgica.

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

M. Piccart, J. Sculier, A. Awada, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ovarian metastasis after radical nephrectomy for primary renal clear cell carcinoma: a diagnostic challenge

J. Donnez, M. Delos, O. Donnez, 2011, Gynecological Surgery.

Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trials.

M. Piccart, E. Tomiak, J. Kerger, 1992, European journal of cancer.

A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors.

M. Piccart, E. W. Van Den Neste, S. Bartholomeus, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Phase I and Pharmacokinetic Study of Docetaxel Administered in Combination with Continuous Intravenous Infusion of 5-Fluorouracil in Patients with Advanced Solid Tumors 1

M. Piccart, S. Bartholomeus, J. Kerger, 2000 .

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.

J. Castelijns, J. Kaanders, A. Awada, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

C. Sempoux, J. Machiels, K. Haustermans, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.

S. Aamdal, R. Paridaens, J. Wanders, 1994, European journal of cancer.

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer.

J. Machiels, M. Berlière, Y. Humblet, 2003, Gynecologic Oncology.

Evaluation of Serum Protein S-100 as a New Melanoma Marker

G. Ghanem, J. Pector, F. Lejeune, 1997 .

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

C. Garbe, E. Espinosa, A. Schueler, 2020, Cancers.

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma

G. Ghanem, A. Awada, F. Journé, 2020, Cancers.

Immunotherapy in gynecological cancers: where are we?

J. Kerger, L. Polastro, Celine Closset, 2020, Current opinion in oncology.

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.

J. Machiels, J. Canon, B. Sautois, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group.

J. Verweij, J. Schornagel, F. Cognetti, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

C. Sempoux, J. Machiels, K. Haustermans, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A multicenter phase II trial of gefitinib 500 mg/day in 193 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy: Interim data

I. Vergote, J. Canon, Y. Humblet, 2005 .

Unusual diffuse liver 18F-FDG uptake in melanoma patient treated by ipilimumab.

P. Flamen, J. Kerger, I. Karfis, 2017, Hellenic journal of nuclear medicine.

A phase I study of sorafenib in association with docetaxel-prednisone in chemonaive metastatic castration-resistant prostate cancer.

J. Machiels, J. Canon, S. Oudard, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel

D. Larsimont, E. Saad, M. Piccart-Gebhart, 2020, Acta oncologica.

A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder

N. Sirtaine, M. Suppa, S. Aspeslagh, 2021, Case Reports in Oncology.

Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

J. Verweij, M. Glabbeke, H. Mouridsen, 1994 .

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

J. Machiels, T. Meyer, S. Topalian, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chinese herbs nephropathy and urinary tract carcinoma

D. Abramowicz, P. Kinnaert, K. Wissing, 1998 .

Treatment algorithm in patients with ovarian cancer

K. K. van de Vijver, I. Vergote, H. Denys, 2020, Facts, views & vision in ObGyn.

The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study

M. Peeters, S. Fieuws, A. D'Hoore, 2012, Annals of Surgical Oncology.

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

M. Nicolson, J. Canon, P. Schőffski, 2012, British Journal of Cancer.

A phase I study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis

M. Piccart-Gebhart, J. Sculier, E. Tomiak, 1991 .

Mitomycin C and Vinblastine in combination with Amifostine in metastatic breast cancer

M. Piccart, A. Awada, J. Kerger, 1997, Supportive Care in Cancer.

Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

R. Paridaens, J. Foubert, D. Rosillon, 2005, Supportive Care in Cancer.

Serum protein S-100 is a useful marker in metastatic melanoma: 192

G. Ghanem, F. Sales, J. Pector, 1997 .

An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers.

J. Machiels, T. Meyer, S. Topalian, 2017 .

Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study.

M. Piccart, A. Awada, T. Gil, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Potential Interactions with Anticancer Agents: A Cross-Sectional Study

A. Spinewine, J. Kerger, L. D'Hondt, 2013, Chemotherapy.

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule

M. Piccart, J. Wanders, J. Verweij, 1999, British Journal of Cancer.

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck

A. Graeff, J. Verweij, J. Schornagel, 1996 .

Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib

F. Willermain, L. Caspers, J. Kerger, 2015, Journal of Ophthalmic Inflammation and Infection.

Clinical and pharmacokinetic phase I study of Docetaxel (TXT) in combination with Cisplatin (DDp) and Fluorouracil (FU) in patients (PTS) with solid tumors

M. Piccart-Gebhart, S. Bartholomeus, J. Kerger, 1998 .

Phase I–II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

J. Castelijns, A. Awada, J. Vermorken, 1999 .

Phase III trial of docetaxel (D), estramustine (E), and prednisone versus docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer (HRPC)

B. Filleul, F. Mazzeo, J. Kerger, 2007 .

Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up

F. Lecouvet, C. Galant, J. Malghem, 2015, Acta Radiologica Open.

Pimasertib (PIM) versus dacarbazine (DTIC) in patients (pts) with cutaneous NRAS melanoma: a controlled, open-label phase II trial with crossover

C. Garbe, E. Espinosa, A. Schueler, 2016 .

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule

M. Piccart, J. Verweij, C. Punt, 1999, British Journal of Cancer.

Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

R. Paridaens, J. Foubert, D. Rosillon, 2005, Supportive Care in Cancer.

Potential Interactions with Anticancer Agents: A Cross-Sectional Study

A. Spinewine, J. Kerger, A. Mouzon, 2013, Chemotherapy.

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma

K. Willard-Gallo, T. Gil, S. Garaud, 2022, Diagnostics.

Study of excretion balance, metabolism and protein binding of Caradiolabelled Taxotere (TXT) (RP56976, NSC628503) in cancer patients.

M. Piccart-Gebhart, E. Tomiak, J. Kerger, 1993 .

Phase II study with taxotere(RP56976) in advanced soft tissue sarcomas of the adult

J. Verweij, M. Glabbeke, H. Mouridsen, 1993 .

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.

F. Caponigro, X. Pivot, A. Awada, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.